GHP News Literature update ViVa week 27-2026 1. JN.1 booster shows surprising reach: cross-hits BA.3.2.2 and keeps a monoclonal option alive In this short immunogenicity study, 25 adults receiving a monovalent JN.1 mRNA vaccine provided serum before and about 12... 6 July, 20267 min read